BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10868495)

  • 1. Opinion of New Zealand physicians on management of acute ischaemic stroke: results of a national survey.
    Ardern-Holmes SL; Raman R; Anderson NE; Charleston AJ; Bennett P
    Aust N Z J Med; 1999 Jun; 29(3):324-30. PubMed ID: 10868495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early management and outcome of acute stroke in Auckland.
    Anderson NE; Bonita R; Broad JB
    Aust N Z J Med; 1997 Oct; 27(5):561-7. PubMed ID: 9404588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug; 14(78):146-52. PubMed ID: 16106599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute stroke treatment in UK hospitals: the Stroke Association survey of consultant opinion.
    Lindley RI; Amayo EO; Marshall J; Sandercock PA; Dennis M; Warlow CP
    J R Coll Physicians Lond; 1995; 29(6):479-84. PubMed ID: 8748103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing attitudes to the management of ischaemic stroke between 1997 and 2004: a survey of New Zealand physicians.
    Somerfield J; Barber PA; Anderson NE; Spriggs D; Charleston A; Bennett P
    Intern Med J; 2006 May; 36(5):276-80. PubMed ID: 16650191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
    Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic stroke management by emergency care physicians at public sector hospitals of Karachi, Pakistan.
    Luni FK; Hamid SA; Mamji S; Baig SM
    J Pak Med Assoc; 2011 Apr; 61(4):375-80. PubMed ID: 21465977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.
    Sandercock PA; van den Belt AG; Lindley RI; Slattery J
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):17-25. PubMed ID: 8429318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and heparin in acute ischaemic stroke in older patients.
    Gubitz GJ; Sandercock PA
    Drugs Aging; 1999 Jul; 15(1):29-36. PubMed ID: 10459730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of stroke in Auckland Hospital in 1996.
    Charleston AJ; Barber PA; Bennett P; Spriggs DA; Harris RG; Anderson NE
    N Z Med J; 1999 Mar; 112(1083):71-4. PubMed ID: 10210307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic drugs and ischaemic stroke.
    Prescrire Int; 2013 Nov; 22(143):270-1. PubMed ID: 24427842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial.
    Berge E; Abdelnoor M; Nakstad PH; Sandset PM
    Lancet; 2000 Apr; 355(9211):1205-10. PubMed ID: 10770301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.
    Sandercock PA; Counsell C; Tseng MC
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000119. PubMed ID: 18646059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study.
    J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):371-6. PubMed ID: 8774398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulants versus antiplatelet agents for acute ischaemic stroke.
    Berge E; Sandercock P
    Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing acute ischaemic stroke in a small island developing state: meeting the guidelines in Barbados.
    Harewood-Marshall AS; Craig LS; Martelly TP; Corbin DOC; Maul L; McIntosh-Clarke D; Blackman T; George KS; Hennis AJM; Hambleton IR; Rose AMC
    BMC Public Health; 2018 May; 18(1):648. PubMed ID: 29788951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy for acute ischaemic stroke: risks versus benefits.
    Lindley RI
    Drug Saf; 1998 Nov; 19(5):373-82. PubMed ID: 9825950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke. Design, service availability, and common practices.
    Goldstein LB; Bonito AJ; Matchar DB; Duncan PW; DeFriese GH; Oddone EZ; Paul JE; Akin DR; Samsa GP
    Stroke; 1995 Sep; 26(9):1607-15. PubMed ID: 7660407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A follow-up survey of clinical practices for the use of heparin, warfarin, and aspirin.
    Alberts MJ; Dawson DV; Massey EW
    Neurology; 1994 Apr; 44(4):618-21. PubMed ID: 8164813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain attack: a new approach to stroke.
    Brown MM
    Clin Med (Lond); 2002; 2(1):60-5. PubMed ID: 11871641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.